BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frantzi M, Bhat A, Latosinska A. Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med 2014;3:7. [PMID: 24679154 DOI: 10.1186/2001-1326-3-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 García-río F, Alcázar-navarrete B, Castillo-villegas D, Cilloniz C, García-ortega A, Leiro-fernández V, Lojo-rodriguez I, Padilla-galo A, Quezada-loaiza CA, Rodriguez-portal JA, Sánchez-de-la-torre M, Sibila O, Martínez-garcía MA. [Translated article] Biological Biomarkers in Respiratory Diseases. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2022.01.010] [Reference Citation Analysis]
2 Cosma G, Brown D, Archer M, Khan M, Graham Pockley A. A survey on computational intelligence approaches for predictive modeling in prostate cancer. Expert Systems with Applications 2017;70:1-19. [DOI: 10.1016/j.eswa.2016.11.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 9.4] [Reference Citation Analysis]
3 da Costa JP, Carvalhais V, Ferreira R, Amado F, Vilanova M, Cerca N, Vitorino R. Proteome signatures—how are they obtained and what do they teach us? Appl Microbiol Biotechnol 2015;99:7417-31. [DOI: 10.1007/s00253-015-6795-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
4 Intasqui P, Camargo M, Antoniassi MP, Cedenho AP, Carvalho VM, Cardozo KHM, Zylbersztejn DS, Bertolla RP. Association between the seminal plasma proteome and sperm functional traits. Fertility and Sterility 2016;105:617-28. [DOI: 10.1016/j.fertnstert.2015.11.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
5 Rafea M, Elkafrawy P, Nasef MM, Elnemr R, Jamal AT. Applying Machine Learning of Erythrocytes Dynamic Antigens Store in Medicine. Front Mol Biosci 2019;6:19. [PMID: 31001536 DOI: 10.3389/fmolb.2019.00019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Upreti D, Pathak A, Kung SK. Development of a standardized flow cytometric method to conduct longitudinal analyses of intracellular CD3ζ expression in patients with head and neck cancer. Oncol Lett 2016;11:2199-206. [PMID: 26998149 DOI: 10.3892/ol.2016.4209] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zorzetti N, D'Andrea V, Lauro A. Proteomic biomarkers in short bowel syndrome : are we ready to use them in clinical activity? Expert Rev Proteomics 2021;18:285-93. [PMID: 33910424 DOI: 10.1080/14789450.2021.1924063] [Reference Citation Analysis]
8 López-Villar E, Martos-Moreno GÁ, Chowen JA, Okada S, Kopchick JJ, Argente J. A proteomic approach to obesity and type 2 diabetes. J Cell Mol Med 2015;19:1455-70. [PMID: 25960181 DOI: 10.1111/jcmm.12600] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
9 Nakayasu ES, Gritsenko M, Piehowski PD, Gao Y, Orton DJ, Schepmoes AA, Fillmore TL, Frohnert BI, Rewers M, Krischer JP, Ansong C, Suchy-Dicey AM, Evans-Molina C, Qian WJ, Webb-Robertson BM, Metz TO. Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation. Nat Protoc 2021;16:3737-60. [PMID: 34244696 DOI: 10.1038/s41596-021-00566-6] [Reference Citation Analysis]
10 Nedelkov D. Mass spectrometry protein tests: ready for prime time (or not). Expert Review of Proteomics 2017;14:1-7. [DOI: 10.1080/14789450.2017.1256777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shen L, Liu X, Zhang H, Lin J, Feng C, Iqbal J. Biomarkers in autism spectrum disorders: Current progress. Clinica Chimica Acta 2020;502:41-54. [DOI: 10.1016/j.cca.2019.12.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
12 Bălănescu P, Bălănescu A, Bălănescu E, Băicuş C. Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020). Rom J Intern Med 2021;59:101-11. [PMID: 33565304 DOI: 10.2478/rjim-2020-0037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu L, Gimple RC, Lau WB, Lau B, Fei F, Shen Q, Liao X, Li Y, Wang W, He Y, Feng M, Bu H, Wang W, Zhou S. THE PRESENT AND FUTURE OF THE MASS SPECTROMETRY-BASED INVESTIGATION OF THE EXOSOME LANDSCAPE. Mass Spectrom Rev 2020;39:745-62. [PMID: 32469100 DOI: 10.1002/mas.21635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Deng J, Wang L, Ni J, Beretov J, Wasinger V, Wu D, Duan W, Graham P, Li Y. Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy. Expert Review of Proteomics 2016;13:905-15. [DOI: 10.1080/14789450.2016.1233065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Maes E, Mertens I, Valkenborg D, Pauwels P, Rolfo C, Baggerman G. Proteomics in cancer research: Are we ready for clinical practice? Crit Rev Oncol Hematol 2015;96:437-48. [PMID: 26277237 DOI: 10.1016/j.critrevonc.2015.07.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
16 Wiktorowicz JE, Brasier AR. Introduction to Clinical Proteomics. Adv Exp Med Biol 2016;919:435-41. [PMID: 27975229 DOI: 10.1007/978-3-319-41448-5_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
17 Ghosh N, Dutta M, Singh B, Banerjee R, Bhattacharyya P, Chaudhury K. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Expert Rev Mol Diagn 2016;16:897-913. [PMID: 27267972 DOI: 10.1080/14737159.2016.1198258] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
18 Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases. J Neurochem 2019;151:397-416. [PMID: 30474862 DOI: 10.1111/jnc.14635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Zhou J, Min Z, Zhang D, Wang W, Marincola F, Wang X. Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer. J Transl Med 2014;12:304. [PMID: 25381811 DOI: 10.1186/s12967-014-0304-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
20 Latosinska A, Frantzi M, Merseburger AS, Mischak H. Promise and Implementation of Proteomic Prostate Cancer Biomarkers. Diagnostics (Basel) 2018;8:E57. [PMID: 30158500 DOI: 10.3390/diagnostics8030057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Tan WS, Tan WP, Tan MY, Khetrapal P, Dong L, deWinter P, Feber A, Kelly JD. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treat Rev 2018;69:39-52. [PMID: 29902678 DOI: 10.1016/j.ctrv.2018.05.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
22 Kosaka PM, Calleja M, Tamayo J. Optomechanical devices for deep plasma cancer proteomics. Semin Cancer Biol 2018;52:26-38. [PMID: 28867489 DOI: 10.1016/j.semcancer.2017.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
23 Umaña-pérez YA, Calderón Rodriguez SI. Estudio proteómico 2DE-DIGE en plasma sanguíneo de pacientes en etapa infantil con leucemia linfoblástica aguda. Rev colomb quim 2019;48:5-15. [DOI: 10.15446/rev.colomb.quim.v48n1.75170] [Reference Citation Analysis]
24 Tang Y, Craven CB, Wawryk NJ, Qiu J, Li F, Li X. Advances in mass spectrometry-based omics analysis of trace organics in water. TrAC Trends in Analytical Chemistry 2020;128:115918. [DOI: 10.1016/j.trac.2020.115918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bringans S, Ito J, Casey T, Thomas S, Peters K, Crossett B, Coleman O, Ebhardt HA, Pennington SR, Lipscombe R. A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease. Clin Proteomics 2020;17:37. [PMID: 33093819 DOI: 10.1186/s12014-020-09302-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Danese E, Montagnana M, Lippi G. Proteomics and frailty: a clinical overview. Expert Review of Proteomics 2018;15:657-64. [DOI: 10.1080/14789450.2018.1505511] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Beger RD, Bhattacharyya S, Yang X, Gill PS, Schnackenberg LK, Sun J, James LP. Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol 2015;89:1497-522. [PMID: 25983262 DOI: 10.1007/s00204-015-1519-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
28 Adeola HA, Soares NC, Paccez JD, Kaestner L, Blackburn JM, Zerbini LF. Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry. Proteomics Clin Appl 2015;9:597-609. [PMID: 25708745 DOI: 10.1002/prca.201400197] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
29 Larrouy-Maumus G. Lipids as Biomarkers of Cancer and Bacterial Infections. Curr Med Chem 2019;26:1924-32. [PMID: 30182838 DOI: 10.2174/0929867325666180904120029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
30 García-Gutiérrez MS, Navarrete F, Sala F, Gasparyan A, Austrich-Olivares A, Manzanares J. Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. Front Psychiatry 2020;11:432. [PMID: 32499729 DOI: 10.3389/fpsyt.2020.00432] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
31 Kim M, Hwang D. Network-Based Protein Biomarker Discovery Platforms. Genomics Inform 2016;14:2-11. [PMID: 27103885 DOI: 10.5808/GI.2016.14.1.2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
32 Jun J, Gim J, Kim Y, Kim H, Yu SJ, Yeo I, Park J, Yoo JJ, Cho YY, Lee DH, Cho EJ, Lee JH, Kim YJ, Lee S, Yoon JH, Kim Y, Park T. Analysis of significant protein abundance from multiple reaction-monitoring data. BMC Syst Biol 2018;12:123. [PMID: 30598095 DOI: 10.1186/s12918-018-0656-9] [Reference Citation Analysis]
33 Nielson CM, Jacobs JM, Orwoll ES. Proteomic studies of bone and skeletal health outcomes. Bone 2019;126:18-26. [PMID: 30954730 DOI: 10.1016/j.bone.2019.03.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Frantzi M, Latosinska A, Merseburger AS, Mischak H. Recent progress in urinary proteome analysis for prostate cancer diagnosis and management. Expert Rev Mol Diagn 2015;15:1539-54. [PMID: 26491818 DOI: 10.1586/14737159.2015.1104248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
35 Chen J, Zheng N. Accelerating protein biomarker discovery and translation from proteomics research for clinical utility. Bioanalysis 2020;12:1469-81. [DOI: 10.4155/bio-2020-0198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Lee SJ, Adler B, Ekström S, Rezeli M, Végvári Á, Park JW, Malm J, Laurell T. Aptamer/ISET-MS: a new affinity-based MALDI technique for improved detection of biomarkers. Anal Chem 2014;86:7627-34. [PMID: 25001319 DOI: 10.1021/ac501488b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
37 Nelson MR, Johnson T, Warren L, Hughes AR, Chissoe SL, Xu CF, Waterworth DM. The genetics of drug efficacy: opportunities and challenges. Nat Rev Genet 2016;17:197-206. [PMID: 26972588 DOI: 10.1038/nrg.2016.12] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 11.7] [Reference Citation Analysis]
38 de Paula Silva L, de Moraes Rego FG, Picheth G, Müller-Santos M, Alberton D. Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring. J Diabetes Metab Disord 2021;20:611-20. [PMID: 34222081 DOI: 10.1007/s40200-021-00788-1] [Reference Citation Analysis]
39 Westbrook JA, Noirel J, Brown JE, Wright PC, Evans CA. Quantitation with chemical tagging reagents in biomarker studies. Prot Clin Appl 2015;9:295-300. [DOI: 10.1002/prca.201400120] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
40 Juanes-velasco P, Galicia N, Pin E, Jara-acevedo R, Carabias-sánchez J, García-valiente R, Lecrevisse Q, Pedreira CE, Gongora R, Sanchez-santos JM, Lorenzo-gil H, Landeira-viñuela A, Bareke H, Orfao A, Nilsson P, Fuentes M. Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid. Cancers 2022;14:449. [DOI: 10.3390/cancers14020449] [Reference Citation Analysis]
41 Shin D, Rhee SJ, Lee J, Yeo I, Do M, Joo EJ, Jung HY, Roh S, Lee SH, Kim H, Bang M, Lee KY, Kwon JS, Ha K, Ahn YM, Kim Y. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry. J Proteome Res 2021;20:3188-203. [PMID: 33960196 DOI: 10.1021/acs.jproteome.1c00058] [Reference Citation Analysis]
42 Hoxhaj I, Govaerts L, Simoens S, Van Dyck W, Huys I, Gutiérrez-Ibarluzea I, Boccia S. A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies. Int J Environ Res Public Health 2020;17:E8001. [PMID: 33143182 DOI: 10.3390/ijerph17218001] [Reference Citation Analysis]
43 Borrebaeck CA. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat Rev Cancer 2017;17:199-204. [PMID: 28154374 DOI: 10.1038/nrc.2016.153] [Cited by in Crossref: 174] [Cited by in F6Publishing: 158] [Article Influence: 34.8] [Reference Citation Analysis]
44 Titz B, Gadaleta RM, Lo Sasso G, Elamin A, Ekroos K, Ivanov NV, Peitsch MC, Hoeng J. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.Int J Mol Sci. 2018;19. [PMID: 30223557 DOI: 10.3390/ijms19092775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
45 Sanguedolce F, Cormio A, Bufo P, Carrieri G, Cormio L. Molecular markers in bladder cancer: Novel research frontiers. Crit Rev Clin Lab Sci 2015;52:242-55. [PMID: 26053693 DOI: 10.3109/10408363.2015.1033610] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
46 Ahn HS, Kim JH, Jeong H, Yu J, Yeom J, Song SH, Kim SS, Kim IJ, Kim K. Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction. Int J Mol Sci 2020;21:E4236. [PMID: 32545899 DOI: 10.3390/ijms21124236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
47 Thomas S, Hao L, Ricke WA, Li L. Biomarker discovery in mass spectrometry-based urinary proteomics. Proteomics Clin Appl 2016;10:358-70. [PMID: 26703953 DOI: 10.1002/prca.201500102] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 12.5] [Reference Citation Analysis]
48 Kupniewska A, Szymanska K, Demkow U. Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality. Adv Exp Med Biol 2018;1040:83-99. [PMID: 28983862 DOI: 10.1007/5584_2017_104] [Reference Citation Analysis]
49 Burg D, Schofield JPR, Brandsma J, Staykova D, Folisi C, Bansal A, Nicholas B, Xian Y, Rowe A, Corfield J, Wilson S, Ward J, Lutter R, Fleming L, Shaw DE, Bakke PS, Caruso M, Dahlen SE, Fowler SJ, Hashimoto S, Horváth I, Howarth P, Krug N, Montuschi P, Sanak M, Sandström T, Singer F, Sun K, Pandis I, Auffray C, Sousa AR, Adcock IM, Chung KF, Sterk PJ, Djukanović R, Skipp PJ, The U-Biopred Study Group. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome. J Proteome Res 2018;17:2072-91. [PMID: 29737851 DOI: 10.1021/acs.jproteome.8b00018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
50 Bhat A, Heinzel A, Mayer B, Perco P, Mühlberger I, Husi H, Merseburger AS, Zoidakis J, Vlahou A, Schanstra JP, Mischak H, Jankowski V. Protein interactome of muscle invasive bladder cancer. PLoS One 2015;10:e0116404. [PMID: 25569276 DOI: 10.1371/journal.pone.0116404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
51 He M, Xia J, Shehab M, Wang X. The development of precision medicine in clinical practice. Clin Transl Med 2015;4:69. [PMID: 26302883 DOI: 10.1186/s40169-015-0069-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
52 Vogelstein JT, Bridgeford EW, Wang Q, Priebe CE, Maggioni M, Shen C. Discovering and deciphering relationships across disparate data modalities. Elife 2019;8:e41690. [PMID: 30644820 DOI: 10.7554/eLife.41690] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
53 Jedinak A, Loughlin KR, Moses MA. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer. Oncotarget 2018;9:32534-50. [PMID: 30197761 DOI: 10.18632/oncotarget.25946] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
54 Ivison S, Des Rosiers C, Lesage S, Rioux JD, Levings MK. Biomarker-guided stratification of autoimmune patients for biologic therapy. Current Opinion in Immunology 2017;49:56-63. [DOI: 10.1016/j.coi.2017.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
55 Xu YW, Chen H, Hong CQ, Chu LY, Yang SH, Huang LS, Guo H, Chen LY, Liu CT, Huang XY, Lin LH, Chen SL, Wu ZY, Peng YH, Xu LY, Li EM. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour. EBioMedicine 2020;51:102566. [PMID: 31901863 DOI: 10.1016/j.ebiom.2019.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 Shi L, Wang L, Hou J, Zhu B, Min Z, Zhang M, Song D, Cheng Y, Wang X. Targeting roles of inflammatory microenvironment in lung cancer and metastasis. Cancer Metastasis Rev 2015;34:319-31. [PMID: 26059063 DOI: 10.1007/s10555-015-9570-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
57 Grobman M, Rindt H, Reinero CR. Proteomic Characterization of Canine Gastric Fluid by Liquid Chromatography-Mass Spectrometry for Development of Protein Biomarkers in Regurgitation, Vomiting, and Cough. Front Vet Sci 2021;8:670007. [PMID: 34307522 DOI: 10.3389/fvets.2021.670007] [Reference Citation Analysis]
58 Kolialexi A, Mavreli D, Papantoniou N. Proteomics for early prenatal screening of pregnancy complications: a 2017 perspective. Expert Rev Proteomics 2017;14:113-5. [PMID: 28002974 DOI: 10.1080/14789450.2017.1275574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
59 Niu F, Wang DC, Lu J, Wu W, Wang X. Potentials of single-cell biology in identification and validation of disease biomarkers. J Cell Mol Med 2016;20:1789-95. [PMID: 27113384 DOI: 10.1111/jcmm.12868] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
60 Kumarasamy G, Kaur G. Protein biomarkers in gynecological cancers: The need for translational research towards clinical applications. Clínica e Investigación en Ginecología y Obstetricia 2022;49:100735. [DOI: 10.1016/j.gine.2021.100735] [Reference Citation Analysis]
61 Ryan KM, Glaviano A, O'Donovan SM, Kolshus E, Dunne R, Kavanagh A, Jelovac A, Noone M, Tucker GM, Dunn MJ, McLoughlin DM. Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study. Transl Psychiatry 2017;7:e1073. [PMID: 28350398 DOI: 10.1038/tp.2017.51] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
62 Yu Y, Bekele S, Pieper R. Quick 96FASP for high throughput quantitative proteome analysis. J Proteomics 2017;166:1-7. [PMID: 28669814 DOI: 10.1016/j.jprot.2017.06.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
63 He T. Implementation of Proteomics in Clinical Trials. Prot Clin Appl 2019;13:1800198. [DOI: 10.1002/prca.201800198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
64 Wozniak JM, Mills RH, Olson J, Caldera JR, Sepich-Poore GD, Carrillo-Terrazas M, Tsai CM, Vargas F, Knight R, Dorrestein PC, Liu GY, Nizet V, Sakoulas G, Rose W, Gonzalez DJ. Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures. Cell 2020;182:1311-1327.e14. [PMID: 32888495 DOI: 10.1016/j.cell.2020.07.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
65 Moazzezy N, Bouzari S, Oloomi M. Comparative Study of Blood, Tissue and Serum Levels of Carcinoembryonic Antigen (CEA) Detection in Breast Cancer. Asian Pac J Cancer Prev 2019;20:2979-85. [PMID: 31653144 DOI: 10.31557/APJCP.2019.20.10.2979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
66 Del Campo M, Jongbloed W, Twaalfhoven HA, Veerhuis R, Blankenstein MA, Teunissen CE. Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays. Front Neurol 2015;6:202. [PMID: 26483753 DOI: 10.3389/fneur.2015.00202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
67 Tirachaimongkol C, Pothacharoen P, Reichart PA, Khongkhunthian P. Relation between the stability of dental implants and two biological markers during the healing period: a prospective clinical study. Int J Implant Dent 2016;2:27. [PMID: 27933572 DOI: 10.1186/s40729-016-0058-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
68 Maes E, Cho WC, Baggerman G. Translating clinical proteomics: the importance of study design. Expert Review of Proteomics 2015;12:217-9. [DOI: 10.1586/14789450.2015.1041512] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
69 Dridi N, Giremus A, Giovannelli JF, Truntzer C, Hadzagic M, Charrier JP, Gerfault L, Ducoroy P, Lacroix B, Grangeat P, Roy P. Bayesian inference for biomarker discovery in proteomics: an analytic solution. EURASIP J Bioinform Syst Biol 2017;2017:9. [PMID: 28710702 DOI: 10.1186/s13637-017-0062-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
70 Zimmer A, Korem Y, Rappaport N, Wilmanski T, Baloni P, Jade K, Robinson M, Magis AT, Lovejoy J, Gibbons SM, Hood L, Price ND. The geometry of clinical labs and wellness states from deeply phenotyped humans. Nat Commun 2021;12:3578. [PMID: 34117230 DOI: 10.1038/s41467-021-23849-8] [Reference Citation Analysis]
71 Sammut SJ, Feichtinger J, Stuart N, Wakeman JA, Larcombe L, McFarlane RJ. A novel cohort of cancer-testis biomarker genes revealed through meta-analysis of clinical data sets. Oncoscience 2014;1:349-59. [PMID: 25594029 DOI: 10.18632/oncoscience.37] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
72 Salvucci M, Zakaria Z, Carberry S, Tivnan A, Seifert V, Kögel D, Murphy BM, Prehn JHM. System-based approaches as prognostic tools for glioblastoma. BMC Cancer 2019;19:1092. [PMID: 31718568 DOI: 10.1186/s12885-019-6280-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
73 Suppers A, van Gool AJ, Wessels HJCT. Integrated Chemometrics and Statistics to Drive Successful Proteomics Biomarker Discovery. Proteomes 2018;6:E20. [PMID: 29701723 DOI: 10.3390/proteomes6020020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
74 Yeat NC, Lin C, Sager M, Lin J. Cancer proteomics: developments in technology, clinical use and commercialization. Expert Rev Proteomics 2015;12:391-405. [PMID: 26145529 DOI: 10.1586/14789450.2015.1051969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
75 Mullish BH, Osborne LS, Marchesi JR, McDonald JA. The implementation of omics technologies in cancer microbiome research. Ecancermedicalscience 2018;12:864. [PMID: 30263055 DOI: 10.3332/ecancer.2018.864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
76 Nedelkov D. Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes. Proteomes 2017;5:E27. [PMID: 29036931 DOI: 10.3390/proteomes5040027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
77 Miah S, Banks CA, Adams MK, Florens L, Lukong KE, Washburn MP. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. Mol Biosyst 2016;13:42-55. [PMID: 27891540 DOI: 10.1039/c6mb00639f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
78 Singh A, Subramani E, Datta Ray C, Rapole S, Chaudhury K. Proteomic-driven biomarker discovery in gestational diabetes mellitus: a review. J Proteomics 2015;127:44-9. [PMID: 26216595 DOI: 10.1016/j.jprot.2015.07.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
79 Hastings JF, O'Donnell YEI, Fey D, Croucher DR. Applications of personalised signalling network models in precision oncology. Pharmacol Ther 2020;212:107555. [PMID: 32320730 DOI: 10.1016/j.pharmthera.2020.107555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
80 de Pontes LG, Altei WF, Galan A, Bilić P, Guillemin N, Kuleš J, Horvatić A, Ribeiro LNM, de Paula E, Pereira VBR, Lucheis SB, Mrljak V, Eckersall PD, Ferreira RS Jr, Dos Santos LD. Extracellular vesicles in infectious diseases caused by protozoan parasites in buffaloes. J Venom Anim Toxins Incl Trop Dis 2020;26:e20190067. [PMID: 32528536 DOI: 10.1590/1678-9199-JVATITD-2019-0067] [Reference Citation Analysis]